When Dr. Jeffrey Velotta, Clinical Professor of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine (KPSOM), returned to the Bay Area in 2014 after years of thoracic surgery training in Boston, New York, and Los Angeles, he thought he understood the landscape of lung cancer.